Phase III Trial of Sirolimus in IBM
Clinical trial NCT04789070 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04789070
- Sponsor
- University of Kansas Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2027-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.